stella
beta
GSL Synthetase Inhibitor Plus Immune Checkpoint Inhibitor and/or Regorafenib in Previously Treated pMMR/MSS CRC. — Stella
Recruiting
Back to Colorectal Cancer trials
Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.
Trial locations
(1 site)
China
China, Beijing, Biotherapeutic Department of Chinsese PLA Gereral Hospital
View full record on ClinicalTrials.gov